3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
Carboplatin
12
Bevacizumab
10
Radiotherapy
9
Paclitaxel
9
Erlotinib Hydrochloride
9
Pemetrexed
7
Docetaxel
5
Taxes
4
Cisplatin
4
pegfilgrastim
3
Gemcitabine
3
Cetuximab
3
Radiotherapy, Conformal
2
Filgrastim
2
veliparib
1
romidepsin
1
pegylated granulocyte colony-stimulating factor
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
Watchful Waiting
1
Vinorelbine
1
Topotecan
1
Thalidomide
1
Temozolomide
1
Surgical Procedures, Operative
1
Sorafenib
1
Selenomethionine
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Pneumonectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Bronchiolo-Alveolar
×
Doxorubicin
×
Clear all
No trials found.